A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Clinical trial NCT05389293 · RECRUITING
Trial details
- NCT number
- NCT05389293
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2027-12-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.